nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—kidney cancer	0.354	1	CbGaD
Meprobamate—ABCB1—Temsirolimus—kidney cancer	0.0815	0.208	CbGbCtD
Meprobamate—ABCB1—Pazopanib—kidney cancer	0.0428	0.109	CbGbCtD
Meprobamate—ABCB1—Dactinomycin—kidney cancer	0.0392	0.0998	CbGbCtD
Meprobamate—ABCB1—Gemcitabine—kidney cancer	0.031	0.0789	CbGbCtD
Meprobamate—CYP2C19—Sorafenib—kidney cancer	0.0308	0.0785	CbGbCtD
Meprobamate—ABCB1—Erlotinib—kidney cancer	0.0306	0.0779	CbGbCtD
Meprobamate—ABCB1—Paclitaxel—kidney cancer	0.028	0.0713	CbGbCtD
Meprobamate—ABCB1—Sorafenib—kidney cancer	0.0249	0.0633	CbGbCtD
Meprobamate—ABCB1—Vinblastine—kidney cancer	0.0245	0.0625	CbGbCtD
Meprobamate—ABCB1—Vincristine—kidney cancer	0.0241	0.0615	CbGbCtD
Meprobamate—ABCB1—Sunitinib—kidney cancer	0.0201	0.0513	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—kidney cancer	0.0151	0.0384	CbGbCtD
Meprobamate—Oedema peripheral—Sunitinib—kidney cancer	0.000895	0.00411	CcSEcCtD
Meprobamate—Agranulocytosis—Dactinomycin—kidney cancer	0.000894	0.00411	CcSEcCtD
Meprobamate—Erythema multiforme—Sorafenib—kidney cancer	0.000893	0.0041	CcSEcCtD
Meprobamate—Paraesthesia—Pazopanib—kidney cancer	0.000879	0.00404	CcSEcCtD
Meprobamate—Agitation—Everolimus—kidney cancer	0.00087	0.004	CcSEcCtD
Meprobamate—Somnolence—Pazopanib—kidney cancer	0.00087	0.004	CcSEcCtD
Meprobamate—Angioedema—Everolimus—kidney cancer	0.000865	0.00398	CcSEcCtD
Meprobamate—Erythema multiforme—Sunitinib—kidney cancer	0.000859	0.00395	CcSEcCtD
Meprobamate—Vertigo—Vinblastine—kidney cancer	0.000854	0.00393	CcSEcCtD
Meprobamate—Leukopenia—Vinblastine—kidney cancer	0.000851	0.00391	CcSEcCtD
Meprobamate—Syncope—Everolimus—kidney cancer	0.000849	0.0039	CcSEcCtD
Meprobamate—Leukopenia—Everolimus—kidney cancer	0.000848	0.0039	CcSEcCtD
Meprobamate—Arrhythmia—Sorafenib—kidney cancer	0.000844	0.00388	CcSEcCtD
Meprobamate—Palpitations—Everolimus—kidney cancer	0.000837	0.00385	CcSEcCtD
Meprobamate—Stomatitis—Vincristine—kidney cancer	0.000835	0.00384	CcSEcCtD
Meprobamate—Loss of consciousness—Everolimus—kidney cancer	0.000832	0.00383	CcSEcCtD
Meprobamate—Ataxia—Paclitaxel—kidney cancer	0.00083	0.00381	CcSEcCtD
Meprobamate—Body temperature increased—Temsirolimus—kidney cancer	0.000821	0.00378	CcSEcCtD
Meprobamate—Syncope—Erlotinib—kidney cancer	0.00082	0.00377	CcSEcCtD
Meprobamate—Chills—Sunitinib—kidney cancer	0.000815	0.00375	CcSEcCtD
Meprobamate—Erythema multiforme—Dactinomycin—kidney cancer	0.000813	0.00374	CcSEcCtD
Meprobamate—Arrhythmia—Sunitinib—kidney cancer	0.000812	0.00373	CcSEcCtD
Meprobamate—Vascular purpura—Capecitabine—kidney cancer	0.00081	0.00372	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.000805	0.0037	CcSEcCtD
Meprobamate—Loss of consciousness—Erlotinib—kidney cancer	0.000803	0.00369	CcSEcCtD
Meprobamate—Stomatitis—Gemcitabine—kidney cancer	0.000792	0.00364	CcSEcCtD
Meprobamate—Petechiae—Doxorubicin—kidney cancer	0.000782	0.00359	CcSEcCtD
Meprobamate—Chills—Dactinomycin—kidney cancer	0.000772	0.00355	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Capecitabine—kidney cancer	0.000768	0.00353	CcSEcCtD
Meprobamate—Hypersensitivity—Temsirolimus—kidney cancer	0.000766	0.00352	CcSEcCtD
Meprobamate—Shock—Everolimus—kidney cancer	0.000761	0.0035	CcSEcCtD
Meprobamate—Agranulocytosis—Gemcitabine—kidney cancer	0.000758	0.00348	CcSEcCtD
Meprobamate—Dermatitis bullous—Capecitabine—kidney cancer	0.000758	0.00348	CcSEcCtD
Meprobamate—Tachycardia—Everolimus—kidney cancer	0.000754	0.00347	CcSEcCtD
Meprobamate—Purpura—Capecitabine—kidney cancer	0.000751	0.00345	CcSEcCtD
Meprobamate—Angioedema—Sorafenib—kidney cancer	0.000751	0.00345	CcSEcCtD
Meprobamate—Asthenia—Temsirolimus—kidney cancer	0.000746	0.00343	CcSEcCtD
Meprobamate—Syncope—Sorafenib—kidney cancer	0.000737	0.00339	CcSEcCtD
Meprobamate—Leukopenia—Sorafenib—kidney cancer	0.000736	0.00338	CcSEcCtD
Meprobamate—Pruritus—Temsirolimus—kidney cancer	0.000735	0.00338	CcSEcCtD
Meprobamate—Shock—Erlotinib—kidney cancer	0.000734	0.00337	CcSEcCtD
Meprobamate—Angioedema—Sunitinib—kidney cancer	0.000723	0.00332	CcSEcCtD
Meprobamate—Loss of consciousness—Sorafenib—kidney cancer	0.000723	0.00332	CcSEcCtD
Meprobamate—Hypotension—Everolimus—kidney cancer	0.000722	0.00332	CcSEcCtD
Meprobamate—Oedema peripheral—Gemcitabine—kidney cancer	0.000718	0.0033	CcSEcCtD
Meprobamate—Diarrhoea—Temsirolimus—kidney cancer	0.000711	0.00327	CcSEcCtD
Meprobamate—Leukopenia—Sunitinib—kidney cancer	0.000708	0.00325	CcSEcCtD
Meprobamate—Asthenia—Pazopanib—kidney cancer	0.000702	0.00323	CcSEcCtD
Meprobamate—Oliguria—Doxorubicin—kidney cancer	0.000698	0.00321	CcSEcCtD
Meprobamate—Paraesthesia—Vinblastine—kidney cancer	0.000697	0.0032	CcSEcCtD
Meprobamate—Paraesthesia—Everolimus—kidney cancer	0.000694	0.00319	CcSEcCtD
Meprobamate—Pruritus—Pazopanib—kidney cancer	0.000693	0.00318	CcSEcCtD
Meprobamate—Erythema multiforme—Gemcitabine—kidney cancer	0.000689	0.00317	CcSEcCtD
Meprobamate—Somnolence—Everolimus—kidney cancer	0.000687	0.00316	CcSEcCtD
Meprobamate—Dizziness—Temsirolimus—kidney cancer	0.000687	0.00316	CcSEcCtD
Meprobamate—Ataxia—Capecitabine—kidney cancer	0.000681	0.00313	CcSEcCtD
Meprobamate—Dysarthria—Doxorubicin—kidney cancer	0.00068	0.00313	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000674	0.0031	CcSEcCtD
Meprobamate—Anaphylactic shock—Sorafenib—kidney cancer	0.000671	0.00308	CcSEcCtD
Meprobamate—Leukopenia—Dactinomycin—kidney cancer	0.00067	0.00308	CcSEcCtD
Meprobamate—Diarrhoea—Pazopanib—kidney cancer	0.00067	0.00308	CcSEcCtD
Meprobamate—Stomatitis—Paclitaxel—kidney cancer	0.000663	0.00305	CcSEcCtD
Meprobamate—Vomiting—Temsirolimus—kidney cancer	0.000661	0.00304	CcSEcCtD
Meprobamate—Shock—Sorafenib—kidney cancer	0.00066	0.00303	CcSEcCtD
Meprobamate—Dermatitis—Temsirolimus—kidney cancer	0.000655	0.00301	CcSEcCtD
Meprobamate—Chills—Gemcitabine—kidney cancer	0.000654	0.00301	CcSEcCtD
Meprobamate—Arrhythmia—Gemcitabine—kidney cancer	0.000651	0.00299	CcSEcCtD
Meprobamate—Headache—Temsirolimus—kidney cancer	0.000651	0.00299	CcSEcCtD
Meprobamate—Dizziness—Pazopanib—kidney cancer	0.000647	0.00298	CcSEcCtD
Meprobamate—Shock—Sunitinib—kidney cancer	0.000635	0.00292	CcSEcCtD
Meprobamate—Vomiting—Pazopanib—kidney cancer	0.000622	0.00286	CcSEcCtD
Meprobamate—Nausea—Temsirolimus—kidney cancer	0.000617	0.00284	CcSEcCtD
Meprobamate—Dermatitis—Pazopanib—kidney cancer	0.000617	0.00283	CcSEcCtD
Meprobamate—Bronchospasm—Capecitabine—kidney cancer	0.000616	0.00283	CcSEcCtD
Meprobamate—Agitation—Vincristine—kidney cancer	0.000615	0.00283	CcSEcCtD
Meprobamate—Headache—Pazopanib—kidney cancer	0.000613	0.00282	CcSEcCtD
Meprobamate—Body temperature increased—Everolimus—kidney cancer	0.000611	0.00281	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—kidney cancer	0.000604	0.00278	CcSEcCtD
Meprobamate—Oedema peripheral—Paclitaxel—kidney cancer	0.000601	0.00276	CcSEcCtD
Meprobamate—Vertigo—Vincristine—kidney cancer	0.000601	0.00276	CcSEcCtD
Meprobamate—Leukopenia—Vincristine—kidney cancer	0.000599	0.00275	CcSEcCtD
Meprobamate—Body temperature increased—Erlotinib—kidney cancer	0.00059	0.00271	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—kidney cancer	0.000585	0.00269	CcSEcCtD
Meprobamate—Nausea—Pazopanib—kidney cancer	0.000582	0.00267	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—kidney cancer	0.000581	0.00267	CcSEcCtD
Meprobamate—Paraesthesia—Sunitinib—kidney cancer	0.00058	0.00266	CcSEcCtD
Meprobamate—Erythema multiforme—Paclitaxel—kidney cancer	0.000577	0.00265	CcSEcCtD
Meprobamate—Hypersensitivity—Vinblastine—kidney cancer	0.000572	0.00263	CcSEcCtD
Meprobamate—Hypersensitivity—Everolimus—kidney cancer	0.00057	0.00262	CcSEcCtD
Meprobamate—Leukopenia—Gemcitabine—kidney cancer	0.000568	0.00261	CcSEcCtD
Meprobamate—Asthenia—Vinblastine—kidney cancer	0.000557	0.00256	CcSEcCtD
Meprobamate—Asthenia—Everolimus—kidney cancer	0.000555	0.00255	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000553	0.00254	CcSEcCtD
Meprobamate—Chills—Paclitaxel—kidney cancer	0.000548	0.00252	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—kidney cancer	0.000547	0.00251	CcSEcCtD
Meprobamate—Pruritus—Everolimus—kidney cancer	0.000547	0.00251	CcSEcCtD
Meprobamate—Anaphylactic shock—Vincristine—kidney cancer	0.000546	0.00251	CcSEcCtD
Meprobamate—Arrhythmia—Paclitaxel—kidney cancer	0.000545	0.00251	CcSEcCtD
Meprobamate—Stomatitis—Capecitabine—kidney cancer	0.000544	0.0025	CcSEcCtD
Meprobamate—Asthenia—Erlotinib—kidney cancer	0.000535	0.00246	CcSEcCtD
Meprobamate—Diarrhoea—Vinblastine—kidney cancer	0.000531	0.00244	CcSEcCtD
Meprobamate—Body temperature increased—Sorafenib—kidney cancer	0.00053	0.00244	CcSEcCtD
Meprobamate—Diarrhoea—Everolimus—kidney cancer	0.000529	0.00243	CcSEcCtD
Meprobamate—Pruritus—Erlotinib—kidney cancer	0.000528	0.00243	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—kidney cancer	0.000522	0.0024	CcSEcCtD
Meprobamate—Agranulocytosis—Capecitabine—kidney cancer	0.000521	0.00239	CcSEcCtD
Meprobamate—Anaphylactic shock—Gemcitabine—kidney cancer	0.000518	0.00238	CcSEcCtD
Meprobamate—Dizziness—Vinblastine—kidney cancer	0.000513	0.00236	CcSEcCtD
Meprobamate—Dizziness—Everolimus—kidney cancer	0.000511	0.00235	CcSEcCtD
Meprobamate—Body temperature increased—Sunitinib—kidney cancer	0.00051	0.00235	CcSEcCtD
Meprobamate—Diarrhoea—Erlotinib—kidney cancer	0.00051	0.00235	CcSEcCtD
Meprobamate—Hypotension—Vincristine—kidney cancer	0.00051	0.00235	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000495	0.00227	CcSEcCtD
Meprobamate—Hypersensitivity—Sorafenib—kidney cancer	0.000494	0.00227	CcSEcCtD
Meprobamate—Oedema peripheral—Capecitabine—kidney cancer	0.000494	0.00227	CcSEcCtD
Meprobamate—Vomiting—Vinblastine—kidney cancer	0.000493	0.00227	CcSEcCtD
Meprobamate—Dizziness—Erlotinib—kidney cancer	0.000493	0.00227	CcSEcCtD
Meprobamate—Vomiting—Everolimus—kidney cancer	0.000491	0.00226	CcSEcCtD
Meprobamate—Paraesthesia—Vincristine—kidney cancer	0.00049	0.00225	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—kidney cancer	0.000488	0.00225	CcSEcCtD
Meprobamate—Agitation—Paclitaxel—kidney cancer	0.000488	0.00224	CcSEcCtD
Meprobamate—Dermatitis—Everolimus—kidney cancer	0.000487	0.00224	CcSEcCtD
Meprobamate—Headache—Vinblastine—kidney cancer	0.000486	0.00223	CcSEcCtD
Meprobamate—Angioedema—Paclitaxel—kidney cancer	0.000486	0.00223	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—kidney cancer	0.000484	0.00223	CcSEcCtD
Meprobamate—Headache—Everolimus—kidney cancer	0.000484	0.00223	CcSEcCtD
Meprobamate—Hypotension—Gemcitabine—kidney cancer	0.000484	0.00222	CcSEcCtD
Meprobamate—Body temperature increased—Dactinomycin—kidney cancer	0.000483	0.00222	CcSEcCtD
Meprobamate—Asthenia—Sorafenib—kidney cancer	0.000481	0.00221	CcSEcCtD
Meprobamate—Vertigo—Paclitaxel—kidney cancer	0.000477	0.00219	CcSEcCtD
Meprobamate—Syncope—Paclitaxel—kidney cancer	0.000477	0.00219	CcSEcCtD
Meprobamate—Leukopenia—Paclitaxel—kidney cancer	0.000476	0.00219	CcSEcCtD
Meprobamate—Hypersensitivity—Sunitinib—kidney cancer	0.000476	0.00219	CcSEcCtD
Meprobamate—Pruritus—Sorafenib—kidney cancer	0.000475	0.00218	CcSEcCtD
Meprobamate—Vomiting—Erlotinib—kidney cancer	0.000474	0.00218	CcSEcCtD
Meprobamate—Erythema multiforme—Capecitabine—kidney cancer	0.000474	0.00218	CcSEcCtD
Meprobamate—Dermatitis—Erlotinib—kidney cancer	0.00047	0.00216	CcSEcCtD
Meprobamate—Palpitations—Paclitaxel—kidney cancer	0.00047	0.00216	CcSEcCtD
Meprobamate—Headache—Erlotinib—kidney cancer	0.000467	0.00215	CcSEcCtD
Meprobamate—Loss of consciousness—Paclitaxel—kidney cancer	0.000467	0.00215	CcSEcCtD
Meprobamate—Paraesthesia—Gemcitabine—kidney cancer	0.000465	0.00214	CcSEcCtD
Meprobamate—Asthenia—Sunitinib—kidney cancer	0.000463	0.00213	CcSEcCtD
Meprobamate—Nausea—Vinblastine—kidney cancer	0.000461	0.00212	CcSEcCtD
Meprobamate—Somnolence—Gemcitabine—kidney cancer	0.000461	0.00212	CcSEcCtD
Meprobamate—Nausea—Everolimus—kidney cancer	0.000459	0.00211	CcSEcCtD
Meprobamate—Diarrhoea—Sorafenib—kidney cancer	0.000459	0.00211	CcSEcCtD
Meprobamate—Pruritus—Sunitinib—kidney cancer	0.000457	0.0021	CcSEcCtD
Meprobamate—Hypersensitivity—Dactinomycin—kidney cancer	0.00045	0.00207	CcSEcCtD
Meprobamate—Chills—Capecitabine—kidney cancer	0.00045	0.00207	CcSEcCtD
Meprobamate—Arrhythmia—Capecitabine—kidney cancer	0.000448	0.00206	CcSEcCtD
Meprobamate—Dizziness—Sorafenib—kidney cancer	0.000444	0.00204	CcSEcCtD
Meprobamate—Nausea—Erlotinib—kidney cancer	0.000443	0.00204	CcSEcCtD
Meprobamate—Diarrhoea—Sunitinib—kidney cancer	0.000442	0.00203	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—kidney cancer	0.000439	0.00202	CcSEcCtD
Meprobamate—Asthenia—Dactinomycin—kidney cancer	0.000439	0.00202	CcSEcCtD
Meprobamate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000434	0.00199	CcSEcCtD
Meprobamate—Body temperature increased—Vincristine—kidney cancer	0.000432	0.00198	CcSEcCtD
Meprobamate—Dizziness—Sunitinib—kidney cancer	0.000427	0.00196	CcSEcCtD
Meprobamate—Shock—Paclitaxel—kidney cancer	0.000427	0.00196	CcSEcCtD
Meprobamate—Vomiting—Sorafenib—kidney cancer	0.000427	0.00196	CcSEcCtD
Meprobamate—Tachycardia—Paclitaxel—kidney cancer	0.000423	0.00195	CcSEcCtD
Meprobamate—Dermatitis—Sorafenib—kidney cancer	0.000423	0.00194	CcSEcCtD
Meprobamate—Headache—Sorafenib—kidney cancer	0.00042	0.00193	CcSEcCtD
Meprobamate—Diarrhoea—Dactinomycin—kidney cancer	0.000418	0.00192	CcSEcCtD
Meprobamate—Vomiting—Sunitinib—kidney cancer	0.000411	0.00189	CcSEcCtD
Meprobamate—Body temperature increased—Gemcitabine—kidney cancer	0.00041	0.00188	CcSEcCtD
Meprobamate—Dermatitis—Sunitinib—kidney cancer	0.000407	0.00187	CcSEcCtD
Meprobamate—Hypotension—Paclitaxel—kidney cancer	0.000405	0.00186	CcSEcCtD
Meprobamate—Headache—Sunitinib—kidney cancer	0.000404	0.00186	CcSEcCtD
Meprobamate—Hypersensitivity—Vincristine—kidney cancer	0.000402	0.00185	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—kidney cancer	0.000399	0.00184	CcSEcCtD
Meprobamate—Nausea—Sorafenib—kidney cancer	0.000399	0.00183	CcSEcCtD
Meprobamate—Vertigo—Capecitabine—kidney cancer	0.000392	0.0018	CcSEcCtD
Meprobamate—Asthenia—Vincristine—kidney cancer	0.000392	0.0018	CcSEcCtD
Meprobamate—Syncope—Capecitabine—kidney cancer	0.000391	0.0018	CcSEcCtD
Meprobamate—Leukopenia—Capecitabine—kidney cancer	0.00039	0.00179	CcSEcCtD
Meprobamate—Paraesthesia—Paclitaxel—kidney cancer	0.000389	0.00179	CcSEcCtD
Meprobamate—Vomiting—Dactinomycin—kidney cancer	0.000389	0.00179	CcSEcCtD
Meprobamate—Somnolence—Paclitaxel—kidney cancer	0.000386	0.00177	CcSEcCtD
Meprobamate—Palpitations—Capecitabine—kidney cancer	0.000385	0.00177	CcSEcCtD
Meprobamate—Nausea—Sunitinib—kidney cancer	0.000384	0.00176	CcSEcCtD
Meprobamate—Loss of consciousness—Capecitabine—kidney cancer	0.000383	0.00176	CcSEcCtD
Meprobamate—Diarrhoea—Vincristine—kidney cancer	0.000374	0.00172	CcSEcCtD
Meprobamate—Asthenia—Gemcitabine—kidney cancer	0.000372	0.00171	CcSEcCtD
Meprobamate—Pruritus—Gemcitabine—kidney cancer	0.000367	0.00168	CcSEcCtD
Meprobamate—Nausea—Dactinomycin—kidney cancer	0.000363	0.00167	CcSEcCtD
Meprobamate—Dizziness—Vincristine—kidney cancer	0.000361	0.00166	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—kidney cancer	0.00036	0.00165	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000357	0.00164	CcSEcCtD
Meprobamate—Diarrhoea—Gemcitabine—kidney cancer	0.000354	0.00163	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—kidney cancer	0.000351	0.00161	CcSEcCtD
Meprobamate—Shock—Capecitabine—kidney cancer	0.00035	0.00161	CcSEcCtD
Meprobamate—Tachycardia—Capecitabine—kidney cancer	0.000347	0.0016	CcSEcCtD
Meprobamate—Vomiting—Vincristine—kidney cancer	0.000347	0.0016	CcSEcCtD
Meprobamate—Dermatitis—Vincristine—kidney cancer	0.000344	0.00158	CcSEcCtD
Meprobamate—Body temperature increased—Paclitaxel—kidney cancer	0.000343	0.00158	CcSEcCtD
Meprobamate—Headache—Vincristine—kidney cancer	0.000342	0.00157	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—kidney cancer	0.000336	0.00154	CcSEcCtD
Meprobamate—Hypotension—Capecitabine—kidney cancer	0.000333	0.00153	CcSEcCtD
Meprobamate—Vomiting—Gemcitabine—kidney cancer	0.000329	0.00151	CcSEcCtD
Meprobamate—Dermatitis—Gemcitabine—kidney cancer	0.000326	0.0015	CcSEcCtD
Meprobamate—Headache—Gemcitabine—kidney cancer	0.000325	0.00149	CcSEcCtD
Meprobamate—Nausea—Vincristine—kidney cancer	0.000324	0.00149	CcSEcCtD
Meprobamate—Paraesthesia—Capecitabine—kidney cancer	0.00032	0.00147	CcSEcCtD
Meprobamate—Hypersensitivity—Paclitaxel—kidney cancer	0.00032	0.00147	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—kidney cancer	0.000318	0.00146	CcSEcCtD
Meprobamate—Asthenia—Paclitaxel—kidney cancer	0.000311	0.00143	CcSEcCtD
Meprobamate—Nausea—Gemcitabine—kidney cancer	0.000308	0.00141	CcSEcCtD
Meprobamate—Pruritus—Paclitaxel—kidney cancer	0.000307	0.00141	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—kidney cancer	0.000305	0.0014	CcSEcCtD
Meprobamate—Diarrhoea—Paclitaxel—kidney cancer	0.000297	0.00136	CcSEcCtD
Meprobamate—Chills—Doxorubicin—kidney cancer	0.00029	0.00133	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—kidney cancer	0.000289	0.00133	CcSEcCtD
Meprobamate—Dizziness—Paclitaxel—kidney cancer	0.000287	0.00132	CcSEcCtD
Meprobamate—Body temperature increased—Capecitabine—kidney cancer	0.000281	0.00129	CcSEcCtD
Meprobamate—Vomiting—Paclitaxel—kidney cancer	0.000276	0.00127	CcSEcCtD
Meprobamate—Dermatitis—Paclitaxel—kidney cancer	0.000273	0.00126	CcSEcCtD
Meprobamate—Headache—Paclitaxel—kidney cancer	0.000272	0.00125	CcSEcCtD
Meprobamate—Hypersensitivity—Capecitabine—kidney cancer	0.000262	0.00121	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—kidney cancer	0.000258	0.00119	CcSEcCtD
Meprobamate—Nausea—Paclitaxel—kidney cancer	0.000258	0.00118	CcSEcCtD
Meprobamate—Asthenia—Capecitabine—kidney cancer	0.000255	0.00117	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—kidney cancer	0.000253	0.00116	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—kidney cancer	0.000252	0.00116	CcSEcCtD
Meprobamate—Pruritus—Capecitabine—kidney cancer	0.000252	0.00116	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—kidney cancer	0.000252	0.00116	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—kidney cancer	0.000248	0.00114	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—kidney cancer	0.000247	0.00114	CcSEcCtD
Meprobamate—Diarrhoea—Capecitabine—kidney cancer	0.000244	0.00112	CcSEcCtD
Meprobamate—Dizziness—Capecitabine—kidney cancer	0.000235	0.00108	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—kidney cancer	0.000229	0.00105	CcSEcCtD
Meprobamate—Vomiting—Capecitabine—kidney cancer	0.000226	0.00104	CcSEcCtD
Meprobamate—Shock—Doxorubicin—kidney cancer	0.000226	0.00104	CcSEcCtD
Meprobamate—Dermatitis—Capecitabine—kidney cancer	0.000224	0.00103	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—kidney cancer	0.000224	0.00103	CcSEcCtD
Meprobamate—Headache—Capecitabine—kidney cancer	0.000223	0.00102	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—kidney cancer	0.000214	0.000985	CcSEcCtD
Meprobamate—Nausea—Capecitabine—kidney cancer	0.000211	0.000972	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—kidney cancer	0.000206	0.000947	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—kidney cancer	0.000204	0.000938	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—kidney cancer	0.000181	0.000834	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—kidney cancer	0.000169	0.000777	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—kidney cancer	0.000165	0.000757	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—kidney cancer	0.000162	0.000746	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—kidney cancer	0.000157	0.000722	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—kidney cancer	0.000152	0.000697	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—kidney cancer	0.000146	0.000671	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—kidney cancer	0.000145	0.000664	CcSEcCtD
Meprobamate—Headache—Doxorubicin—kidney cancer	0.000144	0.000661	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—kidney cancer	0.000136	0.000626	CcSEcCtD
Meprobamate—GABRB3—Ion channel transport—RAF1—kidney cancer	5.28e-05	0.00145	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—BRAF—kidney cancer	5.25e-05	0.00145	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—RAF1—kidney cancer	5.24e-05	0.00144	CbGpPWpGaD
Meprobamate—GABRG2—Ion channel transport—RAF1—kidney cancer	5.18e-05	0.00143	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	5.09e-05	0.0014	CbGpPWpGaD
Meprobamate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.07e-05	0.0014	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.06e-05	0.0014	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—JUN—kidney cancer	5.06e-05	0.00139	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—CTNNB1—kidney cancer	5.02e-05	0.00138	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5e-05	0.00138	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.94e-05	0.00136	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTM1—kidney cancer	4.94e-05	0.00136	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	4.93e-05	0.00136	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.89e-05	0.00135	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTM1—kidney cancer	4.87e-05	0.00134	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—BRAF—kidney cancer	4.87e-05	0.00134	CbGpPWpGaD
Meprobamate—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.84e-05	0.00133	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.83e-05	0.00133	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—BRAF—kidney cancer	4.8e-05	0.00132	CbGpPWpGaD
Meprobamate—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.78e-05	0.00132	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—CYP1A1—kidney cancer	4.68e-05	0.00129	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—RAF1—kidney cancer	4.65e-05	0.00128	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—CYP1A1—kidney cancer	4.62e-05	0.00127	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	4.59e-05	0.00126	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	4.57e-05	0.00126	CbGpPWpGaD
Meprobamate—GABRA1—Ion channel transport—RAF1—kidney cancer	4.53e-05	0.00125	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	4.49e-05	0.00124	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—RAF1—kidney cancer	4.46e-05	0.00123	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.44e-05	0.00122	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	4.43e-05	0.00122	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	4.43e-05	0.00122	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	4.38e-05	0.00121	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.36e-05	0.0012	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.29e-05	0.00118	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.29e-05	0.00118	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—BRAF—kidney cancer	4.27e-05	0.00118	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.26e-05	0.00117	CbGpPWpGaD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.24e-05	0.00117	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.21e-05	0.00116	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—BRAF—kidney cancer	4.19e-05	0.00116	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.18e-05	0.00115	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—MAPK3—kidney cancer	4.18e-05	0.00115	CbGpPWpGaD
Meprobamate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.17e-05	0.00115	CbGpPWpGaD
Meprobamate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	4.15e-05	0.00114	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTP1—kidney cancer	4.14e-05	0.00114	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	4.14e-05	0.00114	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.14e-05	0.00114	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—BRAF—kidney cancer	4.12e-05	0.00114	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ACY1—kidney cancer	4.12e-05	0.00113	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.11e-05	0.00113	CbGpPWpGaD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.1e-05	0.00113	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—BRAF—kidney cancer	4.09e-05	0.00113	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	4.09e-05	0.00113	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	4.07e-05	0.00112	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.07e-05	0.00112	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	4.07e-05	0.00112	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—RAF1—kidney cancer	4.06e-05	0.00112	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	4.04e-05	0.00111	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.04e-05	0.00111	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—BRAF—kidney cancer	4.02e-05	0.00111	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—RAF1—kidney cancer	4.01e-05	0.00111	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4e-05	0.0011	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—MAPK1—kidney cancer	3.98e-05	0.0011	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.86e-05	0.00106	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	3.83e-05	0.00106	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.81e-05	0.00105	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTM1—kidney cancer	3.81e-05	0.00105	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	3.76e-05	0.00104	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.66e-05	0.00101	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.64e-05	0.001	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	3.64e-05	0.001	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL2—kidney cancer	3.62e-05	0.000998	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	3.61e-05	0.000995	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	3.6e-05	0.000993	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.59e-05	0.00099	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—RAF1—kidney cancer	3.56e-05	0.000982	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	3.56e-05	0.000981	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.56e-05	0.000981	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	3.55e-05	0.000979	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.53e-05	0.000973	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—BRAF—kidney cancer	3.51e-05	0.000968	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—RAF1—kidney cancer	3.5e-05	0.000965	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PDHB—kidney cancer	3.5e-05	0.000965	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	3.49e-05	0.000963	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—POMC—kidney cancer	3.49e-05	0.000962	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.48e-05	0.000958	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.48e-05	0.000958	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.48e-05	0.000958	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—RAF1—kidney cancer	3.44e-05	0.000948	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—RAF1—kidney cancer	3.42e-05	0.000942	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.39e-05	0.000934	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—RAF1—kidney cancer	3.36e-05	0.000925	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.33e-05	0.000917	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CCBL1—kidney cancer	3.29e-05	0.000907	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.27e-05	0.000901	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.25e-05	0.000895	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.19e-05	0.000879	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.19e-05	0.000879	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ACY1—kidney cancer	3.18e-05	0.000875	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.13e-05	0.000864	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ACY1—kidney cancer	3.1e-05	0.000854	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.08e-05	0.000849	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—VEGFA—kidney cancer	3.08e-05	0.000848	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.06e-05	0.000843	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3e-05	0.000828	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—RAF1—kidney cancer	2.93e-05	0.000808	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PPAT—kidney cancer	2.85e-05	0.000786	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GLIPR1—kidney cancer	2.85e-05	0.000786	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.79e-05	0.000768	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—MAPK1—kidney cancer	2.79e-05	0.000768	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—MAPK1—kidney cancer	2.75e-05	0.000758	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.71e-05	0.000746	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PDHB—kidney cancer	2.7e-05	0.000744	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—POMC—kidney cancer	2.69e-05	0.000742	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—APRT—kidney cancer	2.65e-05	0.000731	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—FH—kidney cancer	2.65e-05	0.000731	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PDHB—kidney cancer	2.64e-05	0.000726	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.63e-05	0.000724	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CCBL1—kidney cancer	2.54e-05	0.0007	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.54e-05	0.0007	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GPC3—kidney cancer	2.49e-05	0.000687	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CCBL1—kidney cancer	2.48e-05	0.000683	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—MAPK1—kidney cancer	2.44e-05	0.000674	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CA2—kidney cancer	2.43e-05	0.000669	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—MAPK1—kidney cancer	2.4e-05	0.000662	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALAD—kidney cancer	2.36e-05	0.000652	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—MAPK1—kidney cancer	2.36e-05	0.00065	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—MAPK1—kidney cancer	2.34e-05	0.000646	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ST3GAL2—kidney cancer	2.31e-05	0.000636	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—MAPK1—kidney cancer	2.3e-05	0.000634	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.3e-05	0.000633	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALDH1A1—kidney cancer	2.26e-05	0.000622	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.2e-05	0.000607	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPAT—kidney cancer	2.2e-05	0.000607	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.18e-05	0.000602	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.17e-05	0.000599	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC5A3—kidney cancer	2.16e-05	0.000596	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PGK1—kidney cancer	2.16e-05	0.000596	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.16e-05	0.000594	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.15e-05	0.000593	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPAT—kidney cancer	2.15e-05	0.000592	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GLIPR1—kidney cancer	2.15e-05	0.000592	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—LDHB—kidney cancer	2.12e-05	0.000584	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—FH—kidney cancer	2.05e-05	0.000564	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—APRT—kidney cancer	2.05e-05	0.000564	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—MAPK1—kidney cancer	2.01e-05	0.000554	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2e-05	0.000551	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—FH—kidney cancer	2e-05	0.00055	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—APRT—kidney cancer	2e-05	0.00055	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.99e-05	0.000549	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.97e-05	0.000543	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.93e-05	0.000531	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GPC3—kidney cancer	1.92e-05	0.00053	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.92e-05	0.000528	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.88e-05	0.000519	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPC3—kidney cancer	1.88e-05	0.000518	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CA2—kidney cancer	1.87e-05	0.000516	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.85e-05	0.00051	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CA9—kidney cancer	1.84e-05	0.000507	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.84e-05	0.000506	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.83e-05	0.000505	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CA2—kidney cancer	1.83e-05	0.000503	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.83e-05	0.000503	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALAD—kidney cancer	1.82e-05	0.000503	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.8e-05	0.000497	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.78e-05	0.000491	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALAD—kidney cancer	1.78e-05	0.000491	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.77e-05	0.000488	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.74e-05	0.00048	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.74e-05	0.00048	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.74e-05	0.000479	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.74e-05	0.000479	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.72e-05	0.000475	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.7e-05	0.000468	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.68e-05	0.000463	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.67e-05	0.00046	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PGK1—kidney cancer	1.67e-05	0.00046	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LDHB—kidney cancer	1.64e-05	0.000451	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC5A3—kidney cancer	1.63e-05	0.000449	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PGK1—kidney cancer	1.63e-05	0.000449	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LDHB—kidney cancer	1.6e-05	0.00044	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.58e-05	0.000435	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CRABP1—kidney cancer	1.56e-05	0.000431	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.52e-05	0.000418	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ITPR2—kidney cancer	1.45e-05	0.000401	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.44e-05	0.000396	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CA9—kidney cancer	1.42e-05	0.000391	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.4e-05	0.000385	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.39e-05	0.000382	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CA9—kidney cancer	1.38e-05	0.000382	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.37e-05	0.000377	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTT1—kidney cancer	1.33e-05	0.000365	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ACHE—kidney cancer	1.33e-05	0.000365	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.29e-05	0.000356	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SCARB1—kidney cancer	1.25e-05	0.000346	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000342	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PSMD7—kidney cancer	1.22e-05	0.000336	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CRABP1—kidney cancer	1.21e-05	0.000332	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.19e-05	0.000327	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CRABP1—kidney cancer	1.18e-05	0.000324	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—BCHE—kidney cancer	1.15e-05	0.000318	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.15e-05	0.000316	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000314	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ITPR2—kidney cancer	1.12e-05	0.000309	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000304	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ITPR2—kidney cancer	1.09e-05	0.000302	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.03e-05	0.000285	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTT1—kidney cancer	1.02e-05	0.000282	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ACHE—kidney cancer	1.02e-05	0.000282	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTT1—kidney cancer	9.98e-06	0.000275	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ACHE—kidney cancer	9.98e-06	0.000275	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SCARB1—kidney cancer	9.68e-06	0.000267	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS1—kidney cancer	9.58e-06	0.000264	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SCARB1—kidney cancer	9.45e-06	0.00026	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PSMD7—kidney cancer	9.4e-06	0.000259	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS1—kidney cancer	9.35e-06	0.000258	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTP1—kidney cancer	9.19e-06	0.000253	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PSMD7—kidney cancer	9.17e-06	0.000253	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—BCHE—kidney cancer	8.91e-06	0.000245	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC5A5—kidney cancer	8.8e-06	0.000242	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ABCB1—kidney cancer	8.7e-06	0.00024	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—BCHE—kidney cancer	8.7e-06	0.00024	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC5A5—kidney cancer	8.59e-06	0.000237	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC2A1—kidney cancer	8.5e-06	0.000234	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTM1—kidney cancer	8.44e-06	0.000233	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC2A1—kidney cancer	8.3e-06	0.000229	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.25e-06	0.000227	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1A1—kidney cancer	8e-06	0.000221	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	7.91e-06	0.000218	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.19e-06	0.000198	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTP1—kidney cancer	7.09e-06	0.000195	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTP1—kidney cancer	6.92e-06	0.000191	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ABCB1—kidney cancer	6.71e-06	0.000185	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTM1—kidney cancer	6.51e-06	0.000179	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTM1—kidney cancer	6.36e-06	0.000175	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1A1—kidney cancer	6.18e-06	0.00017	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1A1—kidney cancer	6.03e-06	0.000166	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—POMC—kidney cancer	5.97e-06	0.000164	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.07e-06	0.00014	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS2—kidney cancer	4.76e-06	0.000131	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—POMC—kidney cancer	4.6e-06	0.000127	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—POMC—kidney cancer	4.49e-06	0.000124	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTEN—kidney cancer	4.15e-06	0.000114	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS2—kidney cancer	3.67e-06	0.000101	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS2—kidney cancer	3.58e-06	9.88e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTEN—kidney cancer	3.2e-06	8.83e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTEN—kidney cancer	3.13e-06	8.61e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CA—kidney cancer	2.93e-06	8.07e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.26e-06	6.23e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CA—kidney cancer	2.21e-06	6.08e-05	CbGpPWpGaD
